JP2018520647A5 - - Google Patents

Download PDF

Info

Publication number
JP2018520647A5
JP2018520647A5 JP2017558986A JP2017558986A JP2018520647A5 JP 2018520647 A5 JP2018520647 A5 JP 2018520647A5 JP 2017558986 A JP2017558986 A JP 2017558986A JP 2017558986 A JP2017558986 A JP 2017558986A JP 2018520647 A5 JP2018520647 A5 JP 2018520647A5
Authority
JP
Japan
Prior art keywords
composition
enzyme
biological sample
inactivating
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017558986A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018520647A (ja
JP7044554B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/060263 external-priority patent/WO2016180747A1/en
Publication of JP2018520647A publication Critical patent/JP2018520647A/ja
Publication of JP2018520647A5 publication Critical patent/JP2018520647A5/ja
Application granted granted Critical
Publication of JP7044554B2 publication Critical patent/JP7044554B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017558986A 2015-05-10 2016-05-09 自動多重組織染色アッセイの間のアルカリホスファターゼ及びペルオキシダーゼ酵素の同時不活化のための組成物と方法 Active JP7044554B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562159297P 2015-05-10 2015-05-10
US62/159,297 2015-05-10
PCT/EP2016/060263 WO2016180747A1 (en) 2015-05-10 2016-05-09 Compositions and methods for simultaneous inactivation of alkaline phosphatase and peroxidase enzymes during automated multiplex tissue staining assays

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020205107A Division JP2021058193A (ja) 2015-05-10 2020-12-10 自動多重組織染色アッセイの間のアルカリホスファターゼ及びペルオキシダーゼ酵素の同時不活化のための組成物と方法

Publications (3)

Publication Number Publication Date
JP2018520647A JP2018520647A (ja) 2018-08-02
JP2018520647A5 true JP2018520647A5 (cg-RX-API-DMAC7.html) 2019-05-30
JP7044554B2 JP7044554B2 (ja) 2022-03-30

Family

ID=55953158

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017558986A Active JP7044554B2 (ja) 2015-05-10 2016-05-09 自動多重組織染色アッセイの間のアルカリホスファターゼ及びペルオキシダーゼ酵素の同時不活化のための組成物と方法
JP2020205107A Pending JP2021058193A (ja) 2015-05-10 2020-12-10 自動多重組織染色アッセイの間のアルカリホスファターゼ及びペルオキシダーゼ酵素の同時不活化のための組成物と方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020205107A Pending JP2021058193A (ja) 2015-05-10 2020-12-10 自動多重組織染色アッセイの間のアルカリホスファターゼ及びペルオキシダーゼ酵素の同時不活化のための組成物と方法

Country Status (7)

Country Link
US (3) US11162877B2 (cg-RX-API-DMAC7.html)
EP (1) EP3295173B1 (cg-RX-API-DMAC7.html)
JP (2) JP7044554B2 (cg-RX-API-DMAC7.html)
CN (1) CN107980095A (cg-RX-API-DMAC7.html)
AU (1) AU2016261279B2 (cg-RX-API-DMAC7.html)
CA (1) CA2984701C (cg-RX-API-DMAC7.html)
WO (1) WO2016180747A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3853214A1 (en) 2018-09-20 2021-07-28 Ventana Medical Systems, Inc. Coumarin-based crosslinking reagents
JP7346576B2 (ja) 2018-12-25 2023-09-19 ハンクス バイオファーマシューティクス,インコーポレイテッド 抗ox40モノクローナル抗体とその応用
CN116783485A (zh) 2021-01-15 2023-09-19 文塔纳医疗系统公司 储存稳定的笼状半抗原
CN116868054A (zh) 2021-01-25 2023-10-10 文塔纳医疗系统公司 包括用一个或多个可检测部分标记的一种或多种生物标志物的染色生物学样本
WO2022210977A1 (ja) 2021-03-30 2022-10-06 サトーホールディングス株式会社 ラベル構造体及びラベル
CN117177985A (zh) 2021-04-18 2023-12-05 文塔纳医疗系统公司 形态学标志物染色
CN113552362B (zh) * 2021-07-23 2024-08-09 湖北百奥斯生物科技有限公司 一种新型信号放大的免疫荧光试剂盒
CN120359417A (zh) 2022-12-23 2025-07-22 文塔纳医疗系统公司 用于评估抗原呈递机制组分的材料和方法及其用途
WO2025014787A1 (en) 2023-07-07 2025-01-16 Ventana Medical Systems, Inc. Brightfield triplex immunohistochemistry assay for evaluating the colocalization of the er, pr, and ki-67 biomarkers in cells

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3410400C2 (de) * 1984-03-21 1987-04-02 Titmus Eurocon Kontaktlinsen GmbH, 8750 Aschaffenburg Kontaktlinsenpflegesatz und Verfahren zur Pflege von Kontaktlinsen
US5225325A (en) * 1990-03-02 1993-07-06 Ventana Medical Systems, Inc. Immunohistochemical staining method and reagents therefor
US5595707A (en) 1990-03-02 1997-01-21 Ventana Medical Systems, Inc. Automated biological reaction apparatus
CO5080817A1 (es) * 1997-10-21 2001-09-25 Cancer Res Campaign Tech Ltd Determinacion de anormalidades en el crecimiento celular
US6582962B1 (en) 1998-02-27 2003-06-24 Ventana Medical Systems, Inc. Automated molecular pathology apparatus having independent slide heaters
US20030211630A1 (en) 1998-02-27 2003-11-13 Ventana Medical Systems, Inc. Automated molecular pathology apparatus having independent slide heaters
CA2320750C (en) 1998-02-27 2004-08-24 Ventana Medical Systems, Inc. System and method of aspirating and dispensing reagent
SE9804064D0 (sv) * 1998-11-25 1998-11-25 A & Science Invest Ab Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
US20050176072A1 (en) * 2002-06-21 2005-08-11 Martin Michelle D. MTA1 is a predictive and prognostic factor in human breast cancer
US20040248223A1 (en) * 2003-06-05 2004-12-09 Idexx Laboratories, Inc. Reduction of interfering peroxidase activity in peroxidase based detection methods
WO2005033333A2 (en) * 2003-10-07 2005-04-14 Dako Denmark A/S Methods and compositions for the diagnosis of cancer
JP5733734B2 (ja) * 2009-02-19 2015-06-10 国立大学法人 千葉大学 成長因子に誘発されるユークロマチン化(euchromatinization)に必要な、SRC−ファミリーチロシンキナーゼの核局在
CN102458464B (zh) 2009-04-08 2016-08-03 利普厄姆公司 用于治疗炎性疾病的新方法
KR101424414B1 (ko) 2009-10-19 2014-08-01 벤타나 메디컬 시스템즈, 인코포레이티드 현미경 스테이지에 대한 디바이스
DK2714912T3 (en) * 2011-06-01 2018-08-13 Intrexon Actobiotics Nv POLYCISTRONIC EXPRESSION SYSTEM FOR BACTERIA
US20140178169A1 (en) 2011-09-09 2014-06-26 Ventana Medical Systems, Inc. Imaging systems, cassettes, and methods of using the same
CA2867144C (en) 2012-03-27 2019-07-02 Ventana Medical Systems, Inc. Signaling conjugates and methods of use

Similar Documents

Publication Publication Date Title
JP2018520647A5 (cg-RX-API-DMAC7.html)
Lu et al. Hyphal development in Candida albicans requires two temporally linked changes in promoter chromatin for initiation and maintenance
Turner et al. Cloning and characterization of two NAD kinases from Arabidopsis. Identification of a calmodulin binding isoform
Zhang et al. Differential regulation of the ten-eleven translocation (TET) family of dioxygenases by O-linked β-N-acetylglucosamine transferase (OGT)
Wilson et al. Ubiquitylation and degradation of elongating RNA polymerase II: the last resort
Bianchi et al. Dynamic transcription of ubiquitin genes under basal and stressful conditions and new insights into the multiple UBC transcript variants
Dar et al. Molecular cloning of apicoplast-targeted Plasmodium falciparum DNA gyrase genes: unique intrinsic ATPase activity and ATP-independent dimerization of PfGyrB subunit
Crinelli et al. Palytoxin and an Ostreopsis toxin extract increase the levels of mRNAs encoding inflammation-related proteins in human macrophages via p38 MAPK and NF-κB
DE60210621D1 (de) Universelle methode und zusammensetzung zur schnellen lysierung von zellen zur freisetzung von nukleinsäuren und ihre detektion
Pruneski et al. The Paf1 complex represses SER3 transcription in Saccharomyces cerevisiae by facilitating intergenic transcription-dependent nucleosome occupancy of the SER3 promoter
Cucinotta et al. The nucleosome acidic patch regulates the H2B K123 monoubiquitylation cascade and transcription elongation in Saccharomyces cerevisiae
Hartmann et al. Murein Hydrolases in the Envelope of Escherichia coli: Properties in situ and Solubilization from the Envelope
EP2495316A3 (en) Desizing and scouring process of starch
Pérez-Mendoza et al. N-Acetylglucosamine-dependent biofilm formation in Pectobacterium atrosepticum is cryptic and activated by elevated c-di-GMP levels
Andreani et al. Characterisation of the thermostable protease AprX in strains of Pseudomonas fluorescens and impact on the shelf-life of dairy products: Preliminary results
Sirikharin et al. Role of astakine1 in regulating transglutaminase activity
Liberio et al. The crude skin secretion of the pepper frog Leptodactylus labyrinthicus is rich in metallo and serine peptidases
EP3215630A1 (en) Analytical and diagnostic methods utilizing shigella flexneri apyrase
Torres-Huerta et al. Characterization of recombinase DMC1B and its functional role as Rad51 in DNA damage repair in Giardia duodenalis trophozoites
Reuter et al. An NlpC/P60 protein catalyzes a key step in peptidoglycan recycling at the intersection of energy recovery, cell division and immune evasion in the intracellular pathogen Chlamydia trachomatis
Ragu et al. Loss of the thioredoxin reductase Trr1 suppresses the genomic instability of peroxiredoxin tsa1 mutants
Ullmann et al. Comparative clinical sample preparation of DNA and RNA viral nucleic acids for a commercial deep sequencing system (Illumina MiSeq®)
Broglia et al. RNase Y-mediated regulation of the streptococcal pyrogenic exotoxin B
JP2016509835A5 (cg-RX-API-DMAC7.html)
JP2019537434A5 (cg-RX-API-DMAC7.html)